Article Versions Notes

Liquori A, Lesende I, Palomo L, Avetisyan G, Ibáñez M, González-Romero E, Boluda-Navarro M, Morote-Faubel M, Garcia-Ruiz C, Martinez-Valiente C, et al. A Single-Run Next-Generation Sequencing (NGS) Assay for the Simultaneous Detection of Both Gene Mutations and Large Chromosomal Abnormalities in Patients with Myelodysplastic Syndromes (MDS) and Related Myeloid Neoplasms. Cancers. 2021; 13(8):1947. https://doi.org/10.3390/cancers13081947

Liquori, Alessandro, Iván Lesende, Laura Palomo, Gayane Avetisyan, Mariam Ibáñez, Elisa González-Romero, Mireia Boluda-Navarro, Mireya Morote-Faubel, Cristian Garcia-Ruiz, Cristina Martinez-Valiente, and et al. 2021. "A Single-Run Next-Generation Sequencing (NGS) Assay for the Simultaneous Detection of Both Gene Mutations and Large Chromosomal Abnormalities in Patients with Myelodysplastic Syndromes (MDS) and Related Myeloid Neoplasms" Cancers 13, no. 8: 1947. https://doi.org/10.3390/cancers13081947

Liquori, A., Lesende, I., Palomo, L., Avetisyan, G., Ibáñez, M., González-Romero, E., Boluda-Navarro, M., Morote-Faubel, M., Garcia-Ruiz, C., Martinez-Valiente, C., Santiago-Balsera, M., Gomez-Seguí, I., Sanjuan-Pla, A., Sanz, M. A., Sanz, G., Solé, F., Such, E., & Cervera, J. (2021). A Single-Run Next-Generation Sequencing (NGS) Assay for the Simultaneous Detection of Both Gene Mutations and Large Chromosomal Abnormalities in Patients with Myelodysplastic Syndromes (MDS) and Related Myeloid Neoplasms. Cancers, 13(8), 1947. https://doi.org/10.3390/cancers13081947